Eli Lilly In Asia Expansion Overdrive
Oct 27th, 2008
Article originally appeared in Reed Elsevier’s PharmAsia News.
Eli Lilly opened a brand new Asian office and unveiled a major expansion at a second office in as many days as part of a company-wide shift to a new collaborative research and development model, company officials told PharmAsia News.
Lilly opened a new facility Oct. 15 in Shanghai, which will house its R&D headquarters in the region. On Oct. 16, the company then unveiled an expanded state-of-the-art research facility, the Lilly Singapore Center for Drug Discovery, at the Biopolis in Singapore.